BONS Stock Chart & Stats
42.10
>-0.01(-5.03%)
At close: 4:00 PM EST
42.10
>-0.01(-5.03%)
Day’s Range― - ―
52-Week Range21.00 - 60.90
Previous CloseN/A
Volume3.65M
Average Volume (3M)1.16M
Market Cap
₪318.90M
Enterprise Value380.97M
Total Cash (Recent Filing)₪228.00K
Total Debt (Recent Filing)₪8.90M
Price to Earnings (P/E)―
Beta1.47
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding1,168,135,300
10 Day Avg. Volume838,885
30 Day Avg. Volume1,162,235
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-29.68
Price to Sales (P/S)0.00
P/FCF Ratio-11.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bonus Biogroup News
BONS FAQ
What was Bonus Biogroup Ltd.’s price range in the past 12 months?
Bonus Biogroup Ltd. lowest stock price was 21.00 and its highest was 60.90 in the past 12 months.
What is Bonus Biogroup Ltd.’s market cap?
Bonus Biogroup Ltd.’s market cap is ₪318.90M.
When is Bonus Biogroup Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bonus Biogroup Ltd.’s earnings last quarter?
Currently, no data Available
Is Bonus Biogroup Ltd. overvalued?
According to Wall Street analysts Bonus Biogroup Ltd.’s price is currently Overvalued.
Does Bonus Biogroup Ltd. pay dividends?
Bonus Biogroup Ltd. does not currently pay dividends.
What is Bonus Biogroup Ltd.’s EPS estimate?
Bonus Biogroup Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bonus Biogroup Ltd. have?
Bonus Biogroup Ltd. has 1,168,135,300 shares outstanding.
What happened to Bonus Biogroup Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bonus Biogroup Ltd.?
Currently, no hedge funds are holding shares in IL:BONS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bonus Biogroup Ltd.
Bonus BioGroup Ltd. is a clinical-stage biotechnology firm dedicated to creating therapeutic solutions through tissue engineering and cell-based therapies. Their flagship products include BonoFill, which is developed for regenerating bone tissue in maxillofacial and orthopedic applications, and MesenCure, aimed at treating COVID-19 patients suffering from pneumonia and acute respiratory distress syndrome (ARDS), as well as other life-threatening acute inflammatory illnesses. The company's innovation pipeline encompasses bone augmentation treatments for individuals with osteoporosis, cutting-edge nano-materials for drug delivery systems, and advancements in vascularized bone and soft tissue grafts. Originally known as Oceana Advanced Industries Ltd., the company was founded in 1981 and operates from Haifa, Israel.